منابع مشابه
“Current Dengue Vaccine Status”
As the impact of dengue expands, a safe and effective vaccine will benefit the world greatly. Recent progress and novel approaches have advanced the field, but many challenges and unanswered questions remain for dengue vaccine developers. The most advanced dengue vaccine candidate, a chimeric yellow fever dengue (CYD) tetravalent vaccine, was the first dengue vaccine tested in a field efficacy ...
متن کاملA Dengue Vaccine
Denvaxia is the first licensed vaccine for the prevention of dengue. It is a live vaccine developed using recombinant DNA technology. The vaccine is given as three doses over the course of a year and has the potential to prevent hundreds of thousands of hospitalizations each year.
متن کاملDevelopment of Dengue Vaccine
The dengue viruses are estimated to cause several hundred thousand cases of dengue fever, dengue haemorrhagic fever and dengue shock syndrome annually. Attempts to prevent the infection focus on the development of a vaccine that would protect against all four serotypes of the dengue virus. Various biotechnological approaches are being explored, including the use of live attenuated or inactivate...
متن کاملDengue vaccine: WHO position
Beatty ME, et al. Health economics of dengue: a systematic literature review and expert panel's assessment. Am J Trop Med Hyg. 2011;84(3):473-88. Dengue vaccines are currently in development and policymakers need appropriate economic studies to determine their potential financial and public health impact. We searched five databases (PubMed, EMBASE, LILAC, EconLit, and WHOLIS) to identify health...
متن کاملBCG Vaccine-Beginning of its End
In TB, prophylactic immunization plays a key preventive strategy. A live attenuated vaccine called bacille CalmetteGuérin (BCG) was developed way back in 1906 by Albert Calmette and Camille Guérin. The BCG vaccine was derived from an attenuated strain of Mycobacterium bovis and first used on humans in 1921 in France [2]. Currently the vaccine is given to neonates and children as a part of unive...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: MOJ Immunology
سال: 2016
ISSN: 2373-4442
DOI: 10.15406/moji.2016.04.00112